The chr20p13 genomic deletion spans multiple genes (Supplementary Table S2), including RBCK1, whose reduced expression has been shown to be associated with increased tumor cell proliferation and survival, as well as with poor prognosis in breast cancer (Donley et al., 2014). This evidence concerns the gene RBCK1 and breast cancer.